Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04086524
Other study ID # 12345
Secondary ID 3600-105
Status Completed
Phase N/A
First received
Last updated
Start date January 13, 2020
Est. completion date November 30, 2023

Study information

Verified date March 2024
Source University of Waterloo
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to test whether a binocular treatment can improve vision and motor function in young children with amblyopia. The proposed treatment is an animation series that has been modified so that different characters in the animation are presented to each eye. The contrast of the images shown to the amblyopic eye is higher than the contrast of the images shown to the fellow eye. The aim of the treatment is to promote co-operation between the two eyes and improve visual and motor outcomes. We will compare the benefits of this binocular treatment to patching, whereby the better eye is occluded with an eye patch for two hours per day to force the usage of the weaker eye. We hypothesize that the binocular treatment will improve vision and motor outcomes in young children with amblyopia, and that these improvements will be superior to any effects of patching.


Description:

This is a prospective study with study sites in Ontario, Canada (University of Waterloo); Quebec, Canada (University of McGill); Texas, United States of America (Retina Foundation of the Southwest); and Queensland, Australia (Queensland University of Technology). There are three study conditions. 1) binocular treatment at home, 2) binocular treatment in office and, 3) standard patching therapy. Participants will be recruited from university-affiliated clinics and local clinical practices. Following full informed consent, participants will complete baseline testing to confirm eligibility and provide pre-treatment measurements of visual acuity, stereopsis, interocular suppression and motor function. Eligible participants will then be randomized to either binocular treatment or patching. The treatment consists of dichoptically presented children's animations with all characters seen by the amblyopic eye and only a subset of characters seen by the fellow eye. Images shown to the amblyopic eye will be presented at 100% contrast and images presented to the fellow eye will be presented at 20% contrast on session 1 and contrast will increment by 10% of the prior session's contrast level for each subsequent session. Participants will complete 4 x 1-hour sessions per week for two weeks. After 2 weeks of treatment, participants will be offered the opportunity to complete an additional 2 weeks (8 hours) of treatment. Treatment will take place in the home or in-office depending on the study site. The control group will patch for 2 hours every day, at home, for 2 weeks. A calendar will be provided (to both groups) in order for parents to track compliance. After 2 weeks of patching, participants in the control group have the option to crossover to the treatment group for an additional 2 weeks. The primary analysis will compare visual acuity improvements from baseline between the binocular treatment and patching groups after 2 weeks of treatment. Secondary analyses will include comparisons of binocular vision and motor function outcomes between the binocular treatment and patching groups, comparisons of at-home vs. in-office binocular treatment outcomes and an evaluation of crossover effects.


Recruitment information / eligibility

Status Completed
Enrollment 34
Est. completion date November 30, 2023
Est. primary completion date May 1, 2023
Accepts healthy volunteers No
Gender All
Age group 36 Months to 83 Months
Eligibility Inclusion Criteria: - Aged 3-5.9 years old (36-83 months at the time of registration) - Confirmed diagnosis of amblyopia - Best-corrected visual acuity of 20/32 - 20/100 in the amblyopic eye - Best-corrected visual acuity of 20/16 - 20/40 in fellow eye for ages 3-4, and 20/16-20/32 for ages 5-5.9 - Interocular difference in visual acuity of 3 lines or greater - If anisometropic, anisometropia (=1.00D) - Wearing glasses for 8+ weeks + no change in VA w/ glasses for 4-6 weeks - Must be able to experience simultaneous perception when viewing the binocular treatment stimuli with an appropriate interocular contrast offset - Doctor and parent must be willing to forego patching/drops for 4 week study period Exclusion Criteria: - strabismus - Diagnosed eye disease or visual disorder other than amblyopia or anisometropia - >8 weeks premature - Diagnosed or suspected developmental delay (eg. learning disability, autism, Down syndrome) - Diagnosed systemic disease (eg. diabetes, lupus, albinism)

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Binocular cartoon treatment at home
see arm description.
Patching
see arm description
Binocular cartoon treatment in office
see arm description.

Locations

Country Name City State
Australia Queensland University of Technology Brisbane Queesnland
United States Retina Foundation of the Southwest Dallas Texas

Sponsors (4)

Lead Sponsor Collaborator
University of Waterloo McGill University, Queensland University of Technology, Retina Foundation of the Southwest

Countries where clinical trial is conducted

United States,  Australia, 

Outcome

Type Measure Description Time frame Safety issue
Primary Visual acuity Change in visual acuity, measured in logMAR using an electronic HOTV test 2 weeks
Secondary Visual acuity Change in visual acuity, measured in logMAR an electronic HOTV test 4 weeks
Secondary Motor function Change in motor function, measured using the Movement Assessment Battery for Children-2 (version 2) 2 weeks
Secondary Stereopsis Change in stereopsis, measured using the Randot Preschool Stereoacuity Test 2 weeks
Secondary Treatment adherence Self-reported amount of time spent viewing the cartoon or patching compared to amount of prescribed time 4 weeks
Secondary Treatment adherence Self-reported amount of time spent viewing the cartoon or patching compared to amount of prescribed time 2 weeks
Secondary Stereopsis Change in stereopsis, measured using the Randot Preschool Stereoacuity Test 4 weeks
Secondary Motor function Change in motor function, measured using the Movement Assessment Battery for Children-2 (version 2) 4 weeks
Secondary Interocular suppression Change in interocular suppression measured using the Worth 4 dot test 2 weeks
Secondary Interocular suppression Change in interocular suppression measured using the Worth 4 dot test 4 weeks
Secondary Interocular contrast balance Change in interocular contrast balance measured using a dichoptic letter chart 2 weeks
Secondary Interocular contrast balance Change in interocular contrast balance measured using a dichoptic letter chart 4 weeks
See also
  Status Clinical Trial Phase
Recruiting NCT04238065 - A Clinical Trial of Caterna Virtual Reality Facilitating Treatment in Children With Amblyopia N/A
Completed NCT04432181 - Comparison of Deviation Types Among Astigmatic Children With Or Without Amblyopia
Terminated NCT02767856 - Regimens of Intermittent Occlusion Therapy for Amblyopia in Children N/A
Completed NCT02458846 - Efficacy of Visual Screening in Ontario N/A
Completed NCT01190813 - Levodopa for the Treatment of Residual Amblyopia Phase 3
Completed NCT01109459 - Multimodal Physician Intervention to Detect Amblyopia N/A
Completed NCT04313257 - Monocular Action Video Game Treatment of Amblyopia N/A
Completed NCT04315649 - Effect of 3D Movie Viewing on Stereopsis in Strabismus and / or Anisometropic Amblyops N/A
Completed NCT05223153 - OCT-A and Amblyopia
Recruiting NCT05522972 - Establishing New Treatment Approaches for Amblyopia: Perceptual Learning and Video Games N/A
Completed NCT01430247 - Vision Screening for the Detection of Amblyopia N/A
Completed NCT02200211 - Study of Binocular Computer Activities for Treatment of Amblyopia N/A
Recruiting NCT06429280 - Clinical Data Registry of Amblyopia Patients on Luminopia Treatment
Withdrawn NCT04959422 - Assuring Ophthalmologic Follow up N/A
Active, not recruiting NCT05612568 - 5 Years of Eye Screening for ARF in Children Aged <3 Years in Flanders
Recruiting NCT03655912 - Binocular Visual Therapy and Video Games for Amblyopia Treatment. N/A
Recruiting NCT06150391 - Evaluation of Amblyopia Protocols Using a Dichoptic Gabor Videogame Program N/A
Completed NCT03754153 - Binocularly Balanced Viewing Study N/A
Withdrawn NCT02594358 - Caffeine in Amblyopia Study Phase 1/Phase 2
Terminated NCT02246556 - Dichoptic Virtual Reality Therapy for Amblyopia in Adults Phase 1